The relevant information of tumour heterogeneity and the expression of HER2 or HR might otherwise go unnoticed, as biopsy can only deliver a small amount of tissue, and after neoadjuvant chemotherapy, no cancerous tissue for analysis might be available anymore. The gene discussed is ERBB2; the disease is neoplasm.